LifeStance Health Group (NASDAQ:LFST) Stock: Insider Lisa Miller Sells 14,663 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) COO Lisa Miller sold 14,663 shares of the business’s stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $14.68, for a total value of $215,252.84. Following the completion of the transaction, the chief operating officer directly owned 251,904 shares of the company’s stock, valued at approximately $3,697,950.72. The trade was a 5.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

LifeStance Health Group Stock Down 1.5%

Shares of NASDAQ LFST traded down $0.22 during mid-day trading on Thursday, reaching $14.15. 5,017,661 shares of the company were exchanged, compared to its average volume of 3,932,527. LifeStance Health Group, Inc. has a 1 year low of $6.01 and a 1 year high of $15.66. The firm has a 50-day moving average of $12.74 and a 200 day moving average of $9.60. The stock has a market cap of $5.38 billion, a price-to-earnings ratio of 74.48 and a beta of 1.35. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.17.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, November 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $455.86 million for the quarter, compared to analyst estimates of $431.59 million. LifeStance Health Group had a return on equity of 4.82% and a net margin of 4.29%. The company’s revenue for the quarter was up 25.3% compared to the same quarter last year. On average, research analysts expect that LifeStance Health Group, Inc. will post 0.18 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on LFST. Canaccord Genuity Group raised their price target on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a report on Friday, November 6th. JPMorgan Chase & Co. increased their target price on shares of LifeStance Health Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday. Weiss Ratings reissued a “hold (c)” rating on shares of LifeStance Health Group in a research report on Wednesday, November 4th. KeyCorp lifted their price target on shares of LifeStance Health Group from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Friday, November 6th. Finally, BTIG Research upped their price target on LifeStance Health Group from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, LifeStance Health Group presently has an average rating of “Moderate Buy” and an average price target of $14.00.

Institutional Investors Weigh In On LifeStance Health Group

A number of large investors have recently made changes to their positions in LFST. Capstone Investment Advisors LLC acquired a new position in shares of LifeStance Health Group in the 2nd quarter valued at $554,000. Bank of America Corp DE purchased a new position in LifeStance Health Group in the 2nd quarter worth $14,987,000. WINTON GROUP Ltd lifted its position in LifeStance Health Group by 522.3% during the 2nd quarter. WINTON GROUP Ltd now owns 186,589 shares of the company’s stock worth $1,998,000 after acquiring an additional 156,607 shares during the period. Squarepoint Ops LLC acquired a new stake in LifeStance Health Group during the 2nd quarter worth about $1,283,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in LifeStance Health Group during the 2nd quarter worth about $966,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.